New program pairs microdoses of GLP-1 medication with Noom's powerful behavior-change program and at-home biomarker testing to track the health impact of combining GLP-1 therapy with healthy habits.
The CDC's move follows a vote from Health Secretary Robert F. Kennedy Jr.'s vaccine advisory panel that entails a major ...
The acting CDC director adopted controversial guidance from the agency's advisory panel, upending a decadeslong policy. The ...
The US Centers for Disease Control and Prevention officially abandoned universal hepatitis B vaccination for newborns on ...
The award is in response to an “unsolicited proposal,” according to documents in the Federal Register. The University of ...
The CDC formally approved a major change to the childhood immunization schedule by dropping the long-standing recommendation ...
Michigan's chief medical executive split with the CDC Thursday, issuing a standing recommendation to no longer follow federal ...
The Centers for Disease Control and Prevention announced Dec. 16 that it adopted individual-based decision-making for parents deciding whether to give the hepatitis B vaccine, including the birth dose ...
Tribune Content Agency on MSN
The medicine cabinet: Ask the Harvard experts: BMI not best to assess body fat, especially in men
Q: The correlation between BMI and excess body fat seems to be flawed, especially in men. What’s your view? A: Your body mass ...
The Centers for Disease Control and Prevention (CDC) is no longer recommending giving all infants a dose of the hepatitis B vaccine within 24 hours after birth, approving a sweeping and highly ...
Today, Novo Nordisk announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for once-weekly CagriSema (cagrilintide 2.4 mg and semaglutide 2.4 mg) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results